Description
Retsevmo® is used to treat the following cancers which are caused by certain abnormal changes in the RET gene and which have spread and/or cannot be removed by surgery:
– A type of lung cancer called non-small cell lung cancer, in adults who have not previously been treated with a RET inhibitor medicine.
– Thyroid cancer (any type) in adults and adolescents 12 years and older if radioactive iodine treatment, when appropriate, has failed to control your cancer.
– A rare type of thyroid cancer called medullary thyroid cancer in adults and adolescents 12 years and older.
Additional information
| Brand | Retsevmo® |
|---|---|
| Generic name | Selpercatinib hard capsules |
| Form | Oral capsules |
| Strength | 80mg |
| Packing | 56's |
| Manufacturer | Lilly |
| Documents | Either PO or prescription |
| Storage | 20-25°C temperature |
Reviews
There are no reviews yet.